University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II) : an international, double-blind, randomised placebo-controlled trial

Simple item page
dc.contributor.authorCuzick, Jack
dc.contributor.authorSestak, Ivana
dc.contributor.authorForbes, John F.
dc.contributor.authorDowsett, Mitch
dc.contributor.authorKnox, Jill
dc.contributor.authorCawthorn, Simon
dc.contributor.authorSaunders, Christobel
dc.contributor.authorRoche, Nicola
dc.contributor.authorMansel, Robert E.
dc.contributor.authorvon Minckwitz, Gunter
dc.contributor.authorBonanni, Bernardo
dc.contributor.authorPalva, Tiina
dc.contributor.authorHowell, Anthony
dc.contributor.authorIBIS-II investigators
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.date.accessioned2018-12-04T09:20:08Z
dc.date.available2018-12-04T09:20:08Z
dc.date.issued2014-03-22
dc.descriptionThis study was funded by Cancer Research UK (C569/A5032), the National Health and Medical Research Council Australia (GNT300755, GNT569213), Sanofi-Aventis, and AstraZeneca. Sanofi-Aventis and AstraZeneca provided anastrozole and matching placebo. The study sponsor was Queen Mary University of London.en
dc.description.statusPeer revieweden
dc.format.extent8
dc.format.extent462614
dc.identifier104738362
dc.identifiera9a8da32-6b94-4a38-9a78-2d0e94c0cd48
dc.identifier24333009
dc.identifier84896489393
dc.identifier.citationCuzick, J, Sestak, I, Forbes, J F, Dowsett, M, Knox, J, Cawthorn, S, Saunders, C, Roche, N, Mansel, R E, von Minckwitz, G, Bonanni, B, Palva, T, Howell, A & IBIS-II investigators 2014, 'Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II) : an international, double-blind, randomised placebo-controlled trial', The Lancet, vol. 383, no. 9922, pp. 1041-1048. https://doi.org/10.1016/S0140-6736(13)62292-8en
dc.identifier.doi10.1016/S0140-6736(13)62292-8
dc.identifier.iss9922en
dc.identifier.issn0140-6736
dc.identifier.urihttp://hdl.handle.net/2164/11551
dc.identifier.vol383en
dc.language.isoeng
dc.relation.ispartofThe Lanceten
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicineen
dc.subjectCancer Research UKen
dc.subjectC569/A5032en
dc.subject.lccRen
dc.titleAnastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II) : an international, double-blind, randomised placebo-controlled trialen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
1_s2.0_S0140673613622928_main.pdf
Size:
451.77 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.31 KB
Format:
Plain Text
Description:
Download

Collections

All research
University Office research